Compare Injective (INJ) vs Mitosis (MITO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Mitosis — how do they compare? Injective trades at Rp75,721 (market cap Rp7,57T, Rp1,22T 24h volume), while Mitosis trades at Rp435.73 (market cap Rp79M, Rp101,51M 24h volume). The key difference: Injective is far larger — about 95822.8× Mitosis's market cap, and Mitosis's supply is capped (181,3M / 1B MITO (19%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Mitosis for 20 Days on average.
| INJ | MITO | |
|---|---|---|
Market Cap | Rp7,57T | Rp79M |
Volume (24h) | Rp1,22T | Rp101,51M |
Circulating Supply | 100M INJ | 181,3M / 1B MITO (19%) |
Typical Hold Time | 37 Days | 20 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
MITO is trading at Rp450.11 with a market cap of Rp81.9M, showing bullish technical signals across moving averages and oscillators. The token is currently trading near the pivot point of Rp445 with resistance at Rp464 and support at Rp429. With a circulating supply of 181,300 tokens (19% of max supply) and average hold time of 20 days, the token shows moderate network activity.
Overall outlook remains cautiously bullish with technical indicators supporting upward momentum, though RSI levels suggest potential overbought conditions. Key opportunities include strong technical positioning, while risks include low liquidity and regulatory uncertainty in the crypto space.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
